Navigation Links
AcelRx Top-line Data Show Primary Endpoint Achieved in Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Post-Operative Pain in Major Open Abdominal Surgery Patients
Date:3/4/2013

he results than the analyses conducted to date or may identify important implications of the study that are not reflected in these statements, or be subject to differing interpretations by the regulatory agencies; the success, cost and timing of all product development activities and clinical trials; the uncertain clinical development process, including the risk that clinical trials, have an effective design, enroll a sufficient number of patients, or be completed on schedule, if at all; any delays or inability to obtain and maintain regulatory approval of its product candidates in the United States and Europe; its ability to obtain adequate clinical supplies of the drug and device components of its product candidates; its ability to attract funding partners or collaborators with development, regulatory and commercialization expertise; its ability to obtain sufficient financing to complete registration of its product candidates in the United States and Europe; the market potential for its product candidates; the accuracy of AcelRx Pharmaceuticals' estimates regarding expenses, capital requirements and needs for financing; and other risks detailed in the "Risk Factors" and elsewhere in AcelRx Pharmaceuticals' U.S. Securities and Exchange Commission filings and reports, including its Current Report on Form 8-K filed with the SEC on December 7, 2012.  AcelRx Pharmaceuticals undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations.


'/>"/>
SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences
2. AcelRx Pharmaceuticals Provides Clinical Trial Updates
3. AcelRx Appoints Adrian Adams to Board of Directors as Chairman
4. AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common Stock
5. AcelRx Pharmaceuticals Announces Proposed Public Offering Of Common Stock
6. AcelRx Pharmaceuticals to Present at the Piper Jaffray 24th Annual Healthcare Conference
7. AcelRx Announces Achievement of the Primary End-Point in Phase 3 Comparative Study Involving the Sufentanil NanoTab PCA System and Plans to Hold a Conference Call and Webcast Tomorrow to Discuss Top-Line Results
8. AcelRx Pharmaceuticals Reports Third Quarter 2012 Financial Results
9. AcelRx Pharmaceuticals Doses the First Patients in ARX-04 Phase 2 Clinical Study
10. AcelRx Pharmaceuticals to Hold Third Quarter 2012 Financial Results Conference Call and Webcast on November 6, 2012
11. AcelRx Pharmaceuticals Hires Mike A. Royal, M.D. as Chief, Clinical Affairs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... , May 21, 2015  AbbVie (NYSE: ... amounts pursuant to its previously announced offer to acquire ... ("Pharmacyclics") for a mix of cash and AbbVie common ... S-4 filed with the Securities and Exchange Commission by ... the assumption that the exchange offer will expire at ...
(Date:5/21/2015)... May 21, 2015 Delcath Systems, Inc. (NASDAQ: ... study cohort of its expanded Global Phase 2 Clinical ... of  patients with unresectable hepatocellular carcinoma (primary liver cancer, ... study will be conducted at the same hospitals in ... Phase 2 HCC trial, and ICC enrollment is now ...
(Date:5/21/2015)... , May 21, 2015 Dipexium ... stage pharmaceutical company focused on the development and ... research collaborators, today announced a scientific poster presentation ... 3 pivotal trials evaluating Locilex®, its novel, broad ... patients with mild infections of diabetic foot ulcers ...
Breaking Medicine Technology:AbbVie Announces Offer Consideration for Acquisition of Pharmacyclics 2AbbVie Announces Offer Consideration for Acquisition of Pharmacyclics 3AbbVie Announces Offer Consideration for Acquisition of Pharmacyclics 4ICC Cohort Of Delcath's Global Phase 2 Trial Of Melphalan/HDS In Hepatocellular Carcinoma Now Open For Enrollment 2ICC Cohort Of Delcath's Global Phase 2 Trial Of Melphalan/HDS In Hepatocellular Carcinoma Now Open For Enrollment 3ICC Cohort Of Delcath's Global Phase 2 Trial Of Melphalan/HDS In Hepatocellular Carcinoma Now Open For Enrollment 4Dipexium Announces Presentation at 7th International Symposium on the Diabetic Foot 2Dipexium Announces Presentation at 7th International Symposium on the Diabetic Foot 3Dipexium Announces Presentation at 7th International Symposium on the Diabetic Foot 4Dipexium Announces Presentation at 7th International Symposium on the Diabetic Foot 5
... reached listeners in nine,cities across the United States, ... Adams,Morning Show and nine Radio One gospel radio ... Radiothon on Thursday, April 3,2008, benefiting St. Jude ... United States, the national fundraiser helped raise,awareness for ...
... be Presented at European Association for the Study of the ... Liver Annual ... that it has completed its Phase 2 study of its lead,compound, MitoQ(R) ... The European Association for the Study of the Liver,(EASL) Annual Meeting, being ...
Cached Medicine Technology:The Yolanda Adams Morning Show and Radio One Gospel Stations Raise More Than $1 Million During National Radiothon Benefiting St. Jude 2The Yolanda Adams Morning Show and Radio One Gospel Stations Raise More Than $1 Million During National Radiothon Benefiting St. Jude 3Antipodean Pharmaceuticals Announces Completion of Phase 2 Study of Lead Compound MitoQ(R) 2
(Date:5/21/2015)... 21, 2015 WellCare Health Plans, Inc. (NYSE: ... selected by the Florida Healthy Kids Corporation (FHKC) to continue ... age, as part of the Florida Healthy Kids (FHK) program. ... 2015, and may be extended for two additional years at ... children in the FHK program who live in Regions 1, ...
(Date:5/21/2015)... How do you stop head lice epidemics ... and school administrators, but a Miami Lice Removal Company, Lice ... southern Florida, is devising new ways to stop the spread. ... you, the first step is education and prevention. Despite the ... and how they spread are still widely misunderstood. Many continue ...
(Date:5/21/2015)... Many probiotics taken to promote gut ... celiac disease according to a new study by ... tested in the study contained gluten, a protein that ... cause gastrointestinal inflammation for those suffering from celiac disease ... trust in gluten-free claims have turned to global public ...
(Date:5/21/2015)... Angeles, CA (PRWEB) May 21, 2015 LOS ... Driver), the nation’s largest designated driver service, today announced the ... during the Memorial Day weekend. All new customers will receive ... and will be entered to win the grand prize of ... , Memorial Day weekend, traditionally viewed as the start of ...
(Date:5/21/2015)... (PRWEB) May 21, 2015 The potentially ... a substance that seep out of plastic consumables unnoticed—are ... , Leachables can, however, adversely affect experiments and may ... by, for instance, inhibiting enzyme activities in bioassays or ... , Eppendorf is sponsoring a new, free educational ...
Breaking Medicine News(10 mins):Health News:WellCare Selected to Continue Participating in the Florida Healthy Kids Program, Will Serve Nine Florida Regions Under the New Contract 2Health News:Local Lice Removal Company Partners with Schools to Combat Head Lice in the Classroom as Increase in Number of Cases Reported in May. 2Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 2Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 3Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 4Health News:BeMyDD Announces Memorial Day Weekend Campaign to Decrease Drunk Driving Nationwide 2Health News:Eppendorf Webinar Shows How Consumables Can Impact Outcomes in Life Science Research 2Health News:Eppendorf Webinar Shows How Consumables Can Impact Outcomes in Life Science Research 3
... that less antibiotic used in food animals leads to ... a policy of restricting antibiotic use in food-producing animals ... drug-resistant bacteria found in its citizens. ,The ... the leading causes of food borne illness in industrialized ...
... in the April issue of Archives of Dermatology, almost 50% ... advertisements in their newspapers. // Tanning advertisements have been found ... all, there were about 40 tanning advertisements, 15 of whom ... to four months. ,The article carries related information ...
... a process by which a small protein acts directly ... fat while simultaneously suppressing appetite. // This discovery could ... ,The new study by a team led by a ... protein acts directly within muscles to increase the body's ...
... A 12-year-old schoolgirl Hannah Clark from Mountain Ash in South ... had her first heart transplant ten years ago, carried out ... good health with the donor heart that Sir Magdi had ... Magdi as an unusual case decided to leave Hannah's original ...
... dialysis unit at Swaroop Rani Nehru Hospital (SRN hospital) ... with kidney failure //. Two old dialysis machines have ... been installed. ,Following inspection by the Medical ... two new dialysis machines. The patients are being charged ...
... It has been revealed through a study by neuroscientists ... that long-term exposure to stress hormone in mice directly ... depression. April issue of Behavioral Neuroscience, which is published ... ,This would be helpful in treating depression in ...
Cached Medicine News:Health News:Antibiotics Used In Food Animals Causes Antibiotic Resistance In People 2Health News:A Protein May Help In Weight Loss Treatment 2Health News:Reverse Heart Transplant Surgery On A Little Girl Makes History 2Health News:Link Between Stress Hormone And Depression Revealed 2
... mid-sized chest freezer utilizes ultra-thin vacuum ... capacity without increasing the footprint. Patented ... extends compressor life. Bright LED display ... provided for remote user-supplied monitoring system. ...
... The NU-5510 DHD AutoFlow Direct Heat ... filtration guarantying the greatest control of ... both at 95C wet decontamination and ... exceptionally useful for cell line changes ...
... uses ultra-thin vacuum insulation panel technology, ... to increase storage capacity, while maintaining ... boxes or 3,336 samples. Patented heat ... consumption and extends compressor life. Temperature ...
... Series CO2 Incubators by Cedco ... achieves precise temperature and CO2 ... & RH% is displayed digitally. ... RH are displayed digiton large, ...
Medicine Products: